Clinical Trial Update: Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating motexafin gadolinium in combination with radiation therapy for children with newly diagnosed brain stem glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma

Drugs mentioned

• Xcytrin (motexafin gadolinium)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Untreated Childhood Brain Stem Glioma | Phase 1 | Status: COMPLETED